Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma

Int J Mol Sci. 2022 May 5;23(9):5174. doi: 10.3390/ijms23095174.

Abstract

Somatic loss of function mutations in cohesin genes are frequently associated with various cancer types, while cohesin disruption in the germline causes cohesinopathies such as Cornelia-de-Lange syndrome (CdLS). Here, we present the discovery of a recurrent heterozygous RAD21 germline aberration at amino acid position 298 (p.P298S/A) identified in three children with lymphoblastic leukemia or lymphoma in a total dataset of 482 pediatric cancer patients. While RAD21 p.P298S/A did not disrupt the formation of the cohesin complex, it altered RAD21 gene expression, DNA damage response and primary patient fibroblasts showed increased G2/M arrest after irradiation and Mitomycin-C treatment. Subsequent single-cell RNA-sequencing analysis of healthy human bone marrow confirmed the upregulation of distinct cohesin gene patterns during hematopoiesis, highlighting the importance of RAD21 expression within proliferating B- and T-cells. Our clinical and functional data therefore suggest that RAD21 germline variants can predispose to childhood lymphoblastic leukemia or lymphoma without displaying a CdLS phenotype.

Keywords: RAD21; acute lymphoblastic leukemia; cohesin complex; germline cancer predisposition; trio sequencing.

MeSH terms

  • Apoptosis
  • Cell Cycle Proteins* / genetics
  • Cell Cycle Proteins* / metabolism
  • Cell Line, Tumor
  • Child
  • DNA-Binding Proteins* / genetics
  • De Lange Syndrome / genetics
  • G2 Phase Cell Cycle Checkpoints
  • Germ Cells / metabolism
  • Humans
  • Lymphoma* / genetics
  • Mutation
  • Phenotype
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / genetics

Substances

  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • RAD21 protein, human